Literature DB >> 22350573

Additional use of tacrolimus after switching to tocilizumab therapy in patients with primary lack of efficacy of infliximab therapy for rheumatoid arthritis.

Shunsuke Mori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22350573     DOI： 10.1007/s10165-012-0593-1

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN： 1439-7595            Impact factor:   3.023


× No keyword cloud information.
  2 in total

1.  Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use.

Authors:  Nobunori Takahashi; Takayoshi Fujibayashi; Daihei Kida; Yuji Hirano; Takefumi Kato; Daizo Kato; Kiwamu Saito; Atsushi Kaneko; Yuichiro Yabe; Hideki Takagi; Takeshi Oguchi; Hiroyuki Miyake; Tsuyoshi Watanabe; Masatoshi Hayashi; Yasuhide Kanayama; Koji Funahashi; Masahiro Hanabayashi; Shinya Hirabara; Shuji Asai; Toki Takemoto; Kenya Terabe; Nobuyuki Asai; Yutaka Yoshioka; Naoki Ishiguro; Toshihisa Kojima
Journal:  Rheumatol Int       Date:  2015-05-20       Impact factor: 2.631

2.  Evaluation of the Safety and Effectiveness of Add-On Tacrolimus in Patients with Rheumatoid Arthritis Who Failed to Show an Adequate Response to Biological DMARDs: The Interim Results of a Specific Drug Use-Results Survey of Tacrolimus.

Authors:  Kota Ishida; Katsuhisa Shiraki; Takashi Yoshiyasu
Journal:  Drugs R D       Date:  2015-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.